Cue Biopharma Brings Autoimmune Back To The Fore With Ono Deal

 
• By Alaric DeArment
  
Cue and Ono announced a deal to develop Cue's bispecific fusion protein for autoimmune disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business